US5472712A
(en)
*
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5681585A
(en)
*
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US7070806B2
(en)
*
|
1992-01-27 |
2006-07-04 |
Purdue Pharma Lp |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
NZ260408A
(en)
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US5773025A
(en)
*
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
EP1442745A1
(en)
*
|
1993-10-07 |
2004-08-04 |
Euro-Celtique |
Orally administrable opioid formulations having extended duration of effect
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US5965161A
(en)
*
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US20020006438A1
(en)
*
|
1998-09-25 |
2002-01-17 |
Benjamin Oshlack |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
|
US5871776A
(en)
*
|
1995-01-31 |
1999-02-16 |
Mehta; Atul M. |
Controlled-release nifedipine
|
EP0833621B1
(en)
*
|
1995-06-09 |
2002-01-30 |
R.P. Scherer Technologies, Inc. |
Soft gelatin capsules containing particulate material
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
US5733578A
(en)
*
|
1995-11-15 |
1998-03-31 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
US5939356A
(en)
*
|
1996-06-21 |
1999-08-17 |
Southwest Research Institute |
Controlled release coated agricultural products
|
TW477708B
(en)
*
|
1996-09-13 |
2002-03-01 |
Shionogi & Amp Co |
Use of the thermal change to produce a substained release preparations and a process for their production
|
US5807580A
(en)
*
|
1996-10-30 |
1998-09-15 |
Mcneil-Ppc, Inc. |
Film coated tablet compositions having enhanced disintegration characteristics
|
US6180128B1
(en)
*
|
1997-01-27 |
2001-01-30 |
C-Cure Corp. |
Non-carcinogenic substitute for play sand
|
AU8293498A
(en)
|
1997-07-02 |
1999-01-25 |
Euro-Celtique S.A. |
Stabilized sustained release tramadol formulations
|
RS49982B
(sr)
*
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
DK1028820T3
(da)
*
|
1997-10-15 |
2010-04-26 |
Univ South Florida |
Coating til partikelmateriale ved hjælp af superkritisk fluid
|
US6485748B1
(en)
*
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
US8679534B2
(en)
*
|
1997-12-12 |
2014-03-25 |
Andrx Labs, Llc |
HMG-CoA reductase inhibitor extended release formulation
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
PT1041987E
(pt)
|
1997-12-22 |
2006-07-31 |
Euro Celtique Sa |
Forma farmaceutica de dosagem oral, compreendendo uma combinacao de um agonista de opioide e naltrexona
|
US6245357B1
(en)
*
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US5976507A
(en)
*
|
1998-06-04 |
1999-11-02 |
Colgate Palmolive Company |
Dentrifice composition containing encapsulated reactive ingredients
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
DE19901686A1
(de)
*
|
1999-01-18 |
2000-07-20 |
Gruenenthal Gmbh |
Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
|
US6432448B1
(en)
*
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
WO2001019901A2
(en)
*
|
1999-09-14 |
2001-03-22 |
Smithkline Beecham Corporation |
Process for making aqueous coated beadlets
|
US6500462B1
(en)
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
ATE526950T1
(de)
|
1999-10-29 |
2011-10-15 |
Euro Celtique Sa |
Hydrocodon-formulierungen mit gesteuerter freisetzung
|
IL151058A0
(en)
|
2000-02-08 |
2003-04-10 |
Euro Celtique Sa |
Controlled-release compositions containing opioid agonist and antagonist
|
EP2092936B1
(en)
|
2000-02-08 |
2013-03-20 |
Euro-Celtique S.A. |
Tamper-resistant oral opioid agonist formulations
|
GB0007419D0
(en)
†
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Gmbh |
Composition
|
SE0001151D0
(sv)
*
|
2000-03-31 |
2000-03-31 |
Amarin Dev Ab |
Method for producing a controlled-release composition
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
US6663686B1
(en)
|
2000-06-27 |
2003-12-16 |
Agrium, Inc. |
Controlled release fertilizer and method for production thereof
|
WO2002036099A1
(en)
|
2000-10-30 |
2002-05-10 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
EP1339395A2
(en)
|
2000-11-28 |
2003-09-03 |
Fmc Corporation |
Edible pga (propylene glycol alginate) coating composition
|
US6486248B2
(en)
|
2001-01-08 |
2002-11-26 |
Milliken & Company |
Liquid colorant and method
|
US6878309B2
(en)
*
|
2001-02-12 |
2005-04-12 |
Dober Chemical Corp. |
Controlled release cooling additive composition
|
JP2004530676A
(ja)
*
|
2001-04-18 |
2004-10-07 |
ノストラム・ファーマスーティカルズ・インコーポレイテッド |
持続放出性薬学的組成物のための新規コーティング
|
US20110104214A1
(en)
*
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
EP1387673B1
(en)
|
2001-05-11 |
2010-12-29 |
Endo Pharmaceuticals Inc. |
Abuse-resistant controlled-release opioid dosage form
|
US20030070584A1
(en)
*
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
US7052706B2
(en)
*
|
2001-06-08 |
2006-05-30 |
Nostrum Pharmaceuticals, Inc. |
Control release formulation containing a hydrophobic material as the sustained release agent
|
ATE419039T1
(de)
|
2001-07-18 |
2009-01-15 |
Euro Celtique Sa |
Pharmazeutische kombinationen von oxycodon und naloxon
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
RU2004106619A
(ru)
|
2001-08-06 |
2005-07-10 |
Эро-Селтик С.А. (Lu) |
Композиции опиоидного агониста, содержащие высвобождаемый и изолированный антагонист
|
WO2003013433A2
(en)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
WO2003020242A1
(en)
*
|
2001-08-29 |
2003-03-13 |
Srl Technologies, Inc. |
Sustained release preparations
|
JP4925526B2
(ja)
*
|
2001-09-10 |
2012-04-25 |
旭化成ケミカルズ株式会社 |
薬物の混合方法
|
AR036797A1
(es)
|
2001-10-15 |
2004-10-06 |
Ferring Bv |
Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
|
IL146462A
(en)
|
2001-11-13 |
2015-02-26 |
Lycored Bio Ltd |
Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
|
FR2832632B1
(fr)
|
2001-11-26 |
2004-04-23 |
Mane Fils V |
Capsule a solubilisation et liberation du contenu rapides
|
US20030118647A1
(en)
*
|
2001-12-04 |
2003-06-26 |
Pawan Seth |
Extended release tablet of metformin
|
WO2004026235A2
(en)
*
|
2002-09-20 |
2004-04-01 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
US7790905B2
(en)
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
AU2003213719A1
(en)
|
2002-03-01 |
2003-09-16 |
Regents Of The University Of Michigan |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
ES2733051T1
(es)
|
2002-04-05 |
2019-11-27 |
Euro Celtique Sa |
Matriz para liberación sostenida, invariable e independiente de compuestos activos
|
US6958161B2
(en)
*
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
CA2489984A1
(en)
|
2002-06-21 |
2003-12-31 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
US20050226926A1
(en)
*
|
2002-07-25 |
2005-10-13 |
Pfizer Inc |
Sustained-release tablet composition of pramipexole
|
MY136318A
(en)
*
|
2002-07-25 |
2008-09-30 |
Pharmacia Corp |
Sustained-release tablet composition
|
AR040682A1
(es)
*
|
2002-07-25 |
2005-04-13 |
Pharmacia Corp |
Forma de dosificacion una vez al dia de pramipexol
|
JP2005538105A
(ja)
*
|
2002-07-25 |
2005-12-15 |
ファルマシア・コーポレーション |
水不溶性ポリマーおよび水溶性の小孔形成物質からなる2層により被覆された固体剤形の製造方法
|
US20040016276A1
(en)
*
|
2002-07-26 |
2004-01-29 |
Wynnyk Nick P. |
Controlled release fertilizer having improved mechanical handling durability and method for production thereof
|
MXPA05001826A
(es)
|
2002-08-15 |
2005-04-19 |
Euro Celtique Sa |
Composiciones farmaceuticas.
|
US20040043064A1
(en)
*
|
2002-08-29 |
2004-03-04 |
Iorio Theodore L. |
Dosage forms having reduced moisture transmission
|
DK1551372T3
(en)
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
|
ES2206047B1
(es)
*
|
2002-10-22 |
2005-08-01 |
Universidad De Granada |
Sintesis de un transportador de morfina para formas farmaceuticas liquidas orales de accion controlada.
|
US20060148877A1
(en)
*
|
2002-11-26 |
2006-07-06 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations of celcoxib
|
PT2218448E
(pt)
|
2002-12-13 |
2016-01-26 |
Durect Corp |
Sistema oral de entrega de fármaco que compreende materiais transportadores líquidos de alta viscosidade
|
EP2339328A3
(en)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of celecoxib
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
MXPA05011071A
(es)
*
|
2003-04-21 |
2005-12-12 |
Euro Celtique Sa |
Forma de dosificacion resistente a la alteracion que comprende particulas co-extrusionadas de agente adverso y proceso de fabricacion de las misma.
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
JP2007523664A
(ja)
|
2003-04-23 |
2007-08-23 |
フェリング ベスローテン フェンノートシャップ |
医薬組成物用サシェ
|
GB2402679A
(en)
*
|
2003-06-10 |
2004-12-15 |
Reckitt Benckiser Nv |
Automatic washing machine detergent dispensing device
|
US7632521B2
(en)
*
|
2003-07-15 |
2009-12-15 |
Eurand, Inc. |
Controlled release potassium chloride tablets
|
RU2375048C2
(ru)
*
|
2003-07-17 |
2009-12-10 |
Д-Р Редди'С Лабораторис Инк. |
Фармацевтическая композиция с набухающим покрытием
|
US20050147663A1
(en)
*
|
2003-07-17 |
2005-07-07 |
Mohan Mailatur S. |
Method of treatment for improved bioavailability
|
FR2859729B1
(fr)
*
|
2003-09-12 |
2006-02-24 |
Roquette Freres |
Dispersions aqueuses d'au moins un polymere biodegradable
|
SI1663229T1
(sl)
|
2003-09-25 |
2010-08-31 |
Euro Celtique Sa |
Farmacevtske kombinacije hidrokodona in naltreksona
|
US8883204B2
(en)
*
|
2003-12-09 |
2014-11-11 |
Purdue Pharma L.P. |
Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
|
PL1691892T3
(pl)
*
|
2003-12-09 |
2007-07-31 |
Euro Celtique Sa |
Odporna na fizyczne manipulowanie, współwytłaczana postać dawkowania zawierająca środek aktywny i środek przeciwdziałający oraz sposób wytwarzania tej postaci
|
PT1691811E
(pt)
|
2003-12-11 |
2014-10-30 |
Sunovion Pharmaceuticals Inc |
Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
|
EP1547601A1
(en)
*
|
2003-12-23 |
2005-06-29 |
Ferring B.V. |
Coating method
|
TWI483944B
(zh)
*
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
EP1729730B1
(en)
*
|
2004-03-30 |
2009-01-07 |
Euro-Celtique S.A. |
Tamper resistant dosage form comprising an adsorbent and an adverse agent
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
LT1765292T
(lt)
|
2004-06-12 |
2018-01-10 |
Collegium Pharmaceutical, Inc. |
Nuo piktnaudžiavimo apsaugotos vaistų formos
|
EA200900930A1
(ru)
*
|
2004-08-13 |
2009-12-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Композиция таблетки с пролонгированным высвобождением, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
|
CN101849920A
(zh)
*
|
2004-08-13 |
2010-10-06 |
贝林格尔·英格海姆国际有限公司 |
包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途
|
KR20080046751A
(ko)
*
|
2004-09-01 |
2008-05-27 |
유로-셀띠끄 소시에떼 아노님 |
용량 비례적 정상 상태 Cave및 AUC를 갖고, 용량비례적 단일 용량 Cmax보다 작은 오피오이드성 제형
|
US20060093629A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
GB0427455D0
(en)
*
|
2004-12-15 |
2005-01-19 |
Jagotec Ag |
Dosage forms
|
ES2294979T1
(es)
*
|
2005-01-27 |
2008-04-16 |
Alembic Limited |
Formulacion de levetiracetam de liberacion prolongada.
|
GEP20105052B
(en)
*
|
2005-01-28 |
2010-07-26 |
Euro Celtique Sa |
Alcohol resistant dosage forms
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
EP1754471A1
(de)
|
2005-08-18 |
2007-02-21 |
ORAMON-Arzneimittel GmbH & Co. KG |
Verwendung einer quellbaren Zwischenschicht zur Steuerung des Freisetzungsprofils einer festen Arzneimittelformulierung zur peroralen Anwendung und diese enthaltende Arzneimittelformulierung
|
EP1813276A1
(en)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
DK3095447T3
(da)
|
2006-02-03 |
2022-01-31 |
Opko Renal Llc |
Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
|
WO2007092718A2
(en)
*
|
2006-02-07 |
2007-08-16 |
Fmc Corporation |
Coating process to produce controlled release coatings
|
WO2007090881A2
(en)
*
|
2006-02-10 |
2007-08-16 |
Boehringer Ingelheim International Gmbh |
Modified release formulation
|
US20090098202A1
(en)
*
|
2006-02-10 |
2009-04-16 |
Boehringer Ingelheim International Gmbh |
Extended Release Formulation
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
FR2897267A1
(fr)
*
|
2006-02-16 |
2007-08-17 |
Flamel Technologies Sa |
Formes pharmaceutiques multimicroparticulaires pour administration per os
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
KR20150029762A
(ko)
|
2006-06-19 |
2015-03-18 |
알파마 파머슈티컬스 엘엘씨 |
약제학적 조성물
|
CA2655499C
(en)
|
2006-06-21 |
2015-10-27 |
Proventiv Therapeutics, Llc |
Method of treating and preventing secondary hyperparathyroidism_with vitamin d repletion and vitamin d replacemnt therapies
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
GB0624880D0
(en)
*
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
WO2008083709A1
(en)
*
|
2007-01-10 |
2008-07-17 |
Bayer Cropscience Ag |
Insecticidal fertilizer mixtures
|
US7879747B2
(en)
|
2007-03-30 |
2011-02-01 |
Kimberly-Clark Worldwide, Inc. |
Elastic laminates having fragrance releasing properties and methods of making the same
|
ES2403107T3
(es)
|
2007-04-25 |
2013-05-14 |
Cytochroma Inc. |
Método de tratamiento de insuficiencia y deficiencia de vitamina D
|
US20100144684A1
(en)
|
2007-04-25 |
2010-06-10 |
Proventiv Therapeutics, Inc. |
Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease
|
EP3542792B1
(en)
|
2007-04-25 |
2023-06-28 |
EirGen Pharma Ltd. |
Controlled release 25-hydroxyvitamin d
|
US8007707B1
(en)
|
2007-05-15 |
2011-08-30 |
Fresh Products, Inc. |
Method of manufacture air freshening article
|
EP2200613B1
(en)
|
2007-09-21 |
2018-09-05 |
The Johns Hopkins University |
Phenazine derivatives and uses thereof
|
PT2057984E
(pt)
*
|
2007-11-09 |
2010-03-10 |
Acino Pharma Ag |
Comprimidos retard com hidromorfona
|
EP3326621A1
(en)
|
2007-12-06 |
2018-05-30 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
CN106853250A
(zh)
|
2008-04-02 |
2017-06-16 |
赛特克罗公司 |
用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒
|
US8404260B2
(en)
*
|
2008-04-02 |
2013-03-26 |
Bayer Cropscience Lp |
Synergistic pesticide compositions
|
DE102008021473A1
(de)
*
|
2008-04-29 |
2009-11-12 |
Heraeus Kulzer Gmbh |
Mit Antiplaque-Wirkstoff(en) ausgestattete Dentalmaterialien
|
US7883638B2
(en)
|
2008-05-27 |
2011-02-08 |
Dober Chemical Corporation |
Controlled release cooling additive compositions
|
US20100003322A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Lai Felix S |
Enteric coated hydrophobic matrix formulation
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
CN102245171A
(zh)
*
|
2008-11-10 |
2011-11-16 |
株式会社爱茉莉太平洋 |
缓释微粒及其制备方法
|
WO2010099508A1
(en)
|
2009-02-26 |
2010-09-02 |
Theraquest Biosciences, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
MY152279A
(en)
|
2009-03-10 |
2014-09-15 |
Euro Celtique Sa |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
CN105796530A
(zh)
|
2010-03-29 |
2016-07-27 |
赛特克罗公司 |
用于降低甲状旁腺水平的方法和组合物
|
US20120090366A1
(en)
*
|
2010-04-16 |
2012-04-19 |
Taylor Pursell |
Controlled release fertilizer with biopolymer coating and process for making same
|
MX2012012991A
(es)
|
2010-05-11 |
2012-11-30 |
Cima Labs Inc |
Formas de dosificacion oral de liberacion prolongada resistentes al alcohol y que contienen metoprolol.
|
KR20180118801A
(ko)
|
2010-09-01 |
2018-10-31 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태
|
AU2011346757B2
(en)
|
2010-12-22 |
2015-08-20 |
Purdue Pharma L.P. |
Encased tamper resistant controlled release dosage forms
|
JP5638151B2
(ja)
|
2010-12-23 |
2014-12-10 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
不正加工抵抗性の(tamperresistant)固形経口剤形
|
EP2714015B1
(en)
*
|
2011-06-01 |
2017-03-15 |
FMC Corporation |
Controlled release solid dose forms
|
US9243394B2
(en)
|
2011-09-20 |
2016-01-26 |
Fresh Products, Inc. |
Replaceable restroom urinal assemblies, including urinal screens
|
ES2663744T3
(es)
*
|
2011-10-06 |
2018-04-16 |
Novartis Ag |
Composiciones farmacéuticas que comprenden 40-O-(2-hidroxi)etil-rapamicina
|
WO2013126552A1
(en)
|
2012-02-21 |
2013-08-29 |
Auburn University |
Buprenorphine nanoparticle composition and methods thereof
|
ES2716570T3
(es)
|
2012-04-17 |
2019-06-13 |
Purdue Pharma Lp |
Sistemas y procedimientos para tratar o prevenir una respuesta farmacodinámica adversa inducida por opioides
|
US9730885B2
(en)
|
2012-07-12 |
2017-08-15 |
Mallinckrodt Llc |
Extended release, abuse deterrent pharmaceutical compositions
|
WO2014013313A1
(en)
|
2012-07-16 |
2014-01-23 |
Rhodes Technologies |
Process for improved opioid synthesis
|
TW201639855A
(zh)
|
2012-07-16 |
2016-11-16 |
羅德科技公司 |
改良之類鴉片合成方法
|
WO2014123899A1
(en)
|
2013-02-05 |
2014-08-14 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 d 방출 제형
|
US9555113B2
(en)
|
2013-03-15 |
2017-01-31 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
MY183489A
(en)
|
2013-07-23 |
2021-02-22 |
Euro Celtique Sa |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
US9120800B2
(en)
|
2013-08-02 |
2015-09-01 |
Johnson Matthey Public Limited Company |
Process for the preparation of oxymorphone alkaloid and oxymorphone salts
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
TWI539952B
(zh)
|
2014-01-15 |
2016-07-01 |
羅德科技公司 |
改良氧化嗎啡酮合成之方法
|
JP2017502991A
(ja)
|
2014-01-15 |
2017-01-26 |
ローズ テクノロジーズ |
改良されたオキシコドン合成のための方法
|
US9062063B1
(en)
|
2014-03-21 |
2015-06-23 |
Johnson Matthey Public Limited Company |
Forms of oxymorphone hydrochloride
|
EP2937096B1
(en)
|
2014-04-23 |
2019-08-21 |
Julius-Maximilians-Universität Würzburg |
Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity
|
RU2016147009A
(ru)
|
2014-05-01 |
2018-06-04 |
Сан Фармасьютикал Индастриз Лимитед |
Композиции с пролонгированным высвобождением в виде суспензии
|
US20180104197A9
(en)
*
|
2014-05-01 |
2018-04-19 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of metformin
|
US10258583B2
(en)
|
2014-05-01 |
2019-04-16 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of guanfacine
|
US9962336B2
(en)
|
2014-05-01 |
2018-05-08 |
Sun Pharmaceutical Industries Limited |
Extended release suspension compositions
|
BR112017001968A2
(pt)
|
2014-07-30 |
2017-11-21 |
Sun Pharmaceutical Ind Ltd |
embalagem de duas câmaras para uma composição farmacêutica líquida oral de múltiplas doses
|
KR20170047265A
(ko)
|
2014-08-07 |
2017-05-04 |
옵코 아일랜드 글로벌 홀딩스 리미티드 |
25-하이드록시비타민 d를 이용한 보조요법
|
US20170182070A1
(en)
|
2014-10-08 |
2017-06-29 |
Mayne Pharma International Pty Ltd. |
Controlled Release Doxycycline
|
US9849124B2
(en)
|
2014-10-17 |
2017-12-26 |
Purdue Pharma L.P. |
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
|
DE202015102279U1
(de)
|
2014-11-05 |
2015-08-14 |
Fresh Products, Inc. |
Urinalsieb
|
USD778411S1
(en)
|
2014-11-05 |
2017-02-07 |
Fresh Products, Inc. |
Urinal screen
|
USD778412S1
(en)
|
2014-11-10 |
2017-02-07 |
Fresh Products, Inc. |
Urinal screen
|
US9918979B2
(en)
|
2015-01-29 |
2018-03-20 |
Johnson Matthey Public Limited Company |
Process of preparing low ABUK oxymorphone hydrochloride
|
BR112017024732A2
(pt)
|
2015-05-20 |
2018-07-31 |
Novartis Ag |
combinação farmacêutica de everolimus com dactolisibe
|
WO2017015309A1
(en)
|
2015-07-22 |
2017-01-26 |
John Hsu |
Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof
|
EP3436026A1
(en)
|
2016-03-28 |
2019-02-06 |
OPKO Ireland Global Holdings, Ltd. |
Methods of vitamin d treatment
|
US10238803B2
(en)
|
2016-05-02 |
2019-03-26 |
Sun Pharmaceutical Industries Limited |
Drug delivery device for pharmaceutical compositions
|
US10369078B2
(en)
|
2016-05-02 |
2019-08-06 |
Sun Pharmaceutical Industries Limited |
Dual-chamber pack for pharmaceutical compositions
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
CN110114070A
(zh)
|
2016-11-23 |
2019-08-09 |
诺华公司 |
使用依维莫司(everolimus)、达托里昔布(dactolisib)或二者增强免疫反应的方法
|
AU2018388576A1
(en)
|
2017-12-20 |
2020-07-23 |
Fresh Products, Inc. |
Urinal screens
|
WO2019157516A1
(en)
|
2018-02-12 |
2019-08-15 |
resTORbio, Inc. |
Combination therapies
|
EP3594194A1
(en)
|
2018-07-12 |
2020-01-15 |
Casale Sa |
Urea granulation process
|
CN108958335B
(zh)
*
|
2018-07-27 |
2021-08-24 |
中国兵器工业第五九研究所 |
一种气候模块化数控贮存试验系统
|
USD925009S1
(en)
|
2018-10-25 |
2021-07-13 |
Fresh Products, Inc. |
Urinal screen
|
US20220062200A1
(en)
|
2019-05-07 |
2022-03-03 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
WO2020225773A1
(en)
|
2019-05-07 |
2020-11-12 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
US20210315283A1
(en)
*
|
2020-04-13 |
2021-10-14 |
Aki, Inc. |
Disposable diffusing collar stay
|
WO2022167359A1
(en)
|
2021-02-02 |
2022-08-11 |
DuPont Nutrition USA, Inc. |
An aqueous gel composition comprising an ethylcellulose
|
CN115844854A
(zh)
*
|
2022-10-26 |
2023-03-28 |
沈阳药科大学 |
一种微囊型自悬浮茶碱缓释颗粒及其制备方法
|